Charities Fund Research into Treating Chemotherapy-Resistant Neuroblastoma
Solving Kids’ Cancer UK with partners have awarded £500,000 to the Children’s Hospital of Philadelphia (CHOP) and collaborating institutions for research into identifying and treating neuroblastoma in newly diagnosed children.
Exploring the statistics behind neuroblastoma in the UK
A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults.
Together, we are stronger
In the latest edition of her blog our CEO, Gail, reflects on what it means to be part of a parent-led charity.
Research explainer: Single cell study finds sympathoblasts as the root of neuroblastoma
We had We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients.
Research update- March 2021
We have started the year with a new addition to the research team, our Research and Digital Comms Officer Emily Hall who will be focused on sharing and celebrating our research work and helping families navigate the world of neuroblastoma research.
Celebrating women in research: Getting to know Dr Emma Pond
In honour of the International Day for Women and Girls in Science, we've been chatting to our Senior Trials Coordinator Dr Emma pond about her role and the fantastic work she does for SKC.
Advances in Neuroblastoma Research conference 2021
Every 2 years the Advances in Neuroblastoma Research conference invites researchers and clinicians worldwide who work in the field of neuroblastoma to come together and share their latest work.
New Year, new opportunities
In her latest blog our CEO, Gail Jackson reflects on entering a new year and what 2021 and beyond may bring for the charity.
Solving Kids' Cancer's Support for DIPG Community Petition
Solving Kids’ Cancer is proud to stand beside Fiona Govan and the entire DIPG community, following their incredible advocacy work calling for increased funding for research into the most difficult-to-treat childhood cancers.
